Clinical Trial

Intranasal Breast Milk Therapy in HIE

Study acronym: NEO-BRIGHT
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is an open-label prospective single-center randomized controlled trial to evaluate the effect of intranasal breast milk in hypoxic-ischemic encephalopathic neonates receiving therapeutic hypothermia on long term neurodevelopmental outcome compared to standard care.
Trial Details
NCT Number NCT06746532
Lead Sponsor Semmelweis University
Conditions Hypoxic-Ischaemic Encephalopathy, Neonatal Encephalopathy, Perinatal Asphyxia, Neonatal Hypoxic Ischemic Encephalopathy
Enrollment 80 participants
Start Date 2025-02-01
Primary Completion 2028-01 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-24